Article
Version 1
Preserved in Portico This version is not peer-reviewed
Prevalence of Multidrug Resistance Tuberculosis
Version 1
: Received: 11 November 2020 / Approved: 12 November 2020 / Online: 12 November 2020 (08:24:40 CET)
How to cite: Bachani, P.; Kumar, L.; Kumar, N.; Shaukat, F. Prevalence of Multidrug Resistance Tuberculosis. Preprints 2020, 2020110327. https://doi.org/10.20944/preprints202011.0327.v1 Bachani, P.; Kumar, L.; Kumar, N.; Shaukat, F. Prevalence of Multidrug Resistance Tuberculosis. Preprints 2020, 2020110327. https://doi.org/10.20944/preprints202011.0327.v1
Abstract
Introduction Tuberculosis is common in Pakistan. Due to various factors including socioeconomic factors, compliance is poor to anti-tuberculosis drugs, leading to resistance. We aim to determine the prevalence of Multidrug resistance (MDR) tuberculosis in Pakistani population.Methods A prospective observational study was conducted from April 1, 2019, to December 31, 2019, in the Pulmonology department of a tertiary care hospital in Pakistan. Culture and sensitivity were assessed using a sputum sample or, in cases of an absent sputum sample, from Broncho alveolar lavage.ResultsApproximately 71.3% percent patients who had tuberculosis were found to be resistant to Isoniazid and around 48.6% did not respond to Rifampin. Multi-drug resistant was found in 29.4% participants.ConclusionMulti-drug resistance tuberculosis is very prevalent in Pakistan, which may increase burden on health care system and may lead to various complications of tuberculosis.
Keywords
Multi-drug resistance; Tuberculosis; Pakistan
Subject
Medicine and Pharmacology, Epidemiology and Infectious Diseases
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment